KRISHGEN BIOSYSTEMS of Mumbai, Maharashtra at MEDICA 2022 in Düsseldorf -- COMPAMED Trade Fair
Manage stand orders
Select Option

Submit your contact details

Provide your contact details to the exhibitor. Optionally, you may also add a personal message.

Please log in

You must be logged in to send the contact request.

An error has occurred

Please check your internet connection or try again later.

Message has been sent

Your message to the exhibitor was sent successfully.

Company news

Date

Topic

29 Oct 2022

New State of the Art Manufacturing Facility for IVD ELISA

Krishgen is proud to announce the completion and inauguration of our new, state of the art, 8000 sq ft manufacturing lab close to Mumbai. 
- ISO Class 7 / 8 Cleanrooms
- ISO 13485 Certified
- JAS ANZ Certified
- CDSCO (India) Certified
- Automated Production Lines

This new facility forms the primary manufacturing lab for all our IVD ELISA, with a manufacturing capability of 500 plates / day.

More Less

01 Oct 2022

Launching Bispecific Antibody ELISA: some of the world's most unique assays for PK analysis

Bispecific Antibody drugs have been shown to be clinically superior to monoclonal antibodies in their specificity and have a wide range of therapeutic applications under tumor and other diseases. Their clear advantage is the enhanced specificity, targetability and reduced off-target toxicity they allow for.

Krishgen offers a range of unique, highly specific ELISA for drug interaction, dosage regimen analysis and other pharmacokinetic studies for biosimilars and generics.

- The kit is developed using specific anti-idiotypic antibodies
- Validated on a seven step protocol as per US FDA and EMA guidelines for bioassays
- Calibrated against the innovator drug itself 

Contact our team at sales@krishgen.com to learn more.

More Less

Please log in

You must be logged in to use matchmaking